Anticoagulant Reversal Table
exp date isn't null, but text field is
Drug Class |
Drug names |
Monitoring Parameters |
Half-life |
Reversal Agents |
|
Oral Vitamin K Antagonists |
Warfarin |
PT/INR |
36-48 hours |
Life-threatening: 4-Factor PCC*+ IV Vitamin K Non-urgent: IV Vitamin K Alternative: FFP |
|
Heparins |
Unfractionated Heparin |
Heparin |
Anti-Factor Xa activity level, aPTT |
60-90 minutes |
Protamine |
Low Molecular Weight Heparin |
Enoxaparin, Dalteparin |
Anti-Factor Xa activity level |
3-6 hours* |
Protamine |
|
Synthetic Factor Xa Inhibitors |
Fondaparinux |
Anti-Factor Xa activity level |
17-21 hours* |
FEIBA or Factor VIIa |
|
Direct Oral Anticoagulants (DOACs) |
Direct Thrombin Inhibitors |
Dabigatran |
aPTT |
12-14 hours* |
Idaracizumab |
Direct Xa Inhibitors |
Rivaroxaban, Apixaban, Edoxaban, Betrixaban |
Anti-Factor Xa activity level (Rivaroxaban, Apixaban) |
|
Intracranial Hemorrhage: Andexanet Alfa** Other life-threatening bleed: 4-Factor PCC* |
* May be prolonged in acute kidney injury or renal failure
* K-Centra (4 factor PCC) Use restricted to neurosurgery, stroke team, emergency medicine, trauma, and hematology
** Andexanet Restricted to emergency department, neurosurgery, stroke team, neurocritical care, or hematology approval
₸ May be prolonged in the setting of hepatic injury or failure